Company Overview and News
WILMINGTON, Del., May 22, 2018 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that it expects its total second quarter 2018 revenue to be between $63 million and $67 million. This range is comprised primarily of recurring revenue and includes less than $1 million of non-recurring revenue.
WILMINGTON, Del., May 22, 2018 (GLOBE NEWSWIRE) -- InterDigital (NASDAQ:IDCC), a mobile technology research and development company and member of 5TONIC, the first 5G research laboratory in Spain, announced that the laboratory has been recognized as a Digital Innovation Hub by the European Union (EU). Founded originally by experts from Telefonica and the research institute IMDEA Networks, the EU’s recognition highlights the important role that 5TONIC is playing in the development and testing of next-generation 5G mobile technology networks.
WILMINGTON, Del., May 18, 2018 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that the company will be presenting at and attending various investor conferences in May and June.
WILMINGTON, Del., May 17, 2018 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced the appointment of Dr. Henry Tirri as Chief Technology Officer.
WILMINGTON, Del., May 09, 2018 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced two new commercial service customers of the oneTRANSPORT™ data marketplace. Local authorities Hertfordshire County Council and Buckinghamshire County Council will join an actively expanding ecosystem that currently includes Northamptonshire County Council, Oxfordshire County Council, Arup, WorldSensing and Traak Systems.
This is the 6th month I have officially tracked dividend income, and it was slightly below expectations with a total of $619.98 of dividends received.
Good day and welcome to the InterDigital's First Quarter 2018 Earnings Call. Today's conference is being recorded.
Document Table of Contents
The earnings season is off to a solid start with decent performance across the table. About 87 S&P 500 members have already released their results till Apr 20. Total earnings for these companies are up 25% year over year on 10.7% higher revenues, with 82.8% beating earnings estimates and 67.8% surpassing top-line expectations. Based on the hitherto observed pattern, first-quarter 2018 is anticipated to register healthy double-digit percentage earnings growth on a year-over-year basis.
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Prox
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WILMINGTON, Del., April 09, 2018 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that the company will release its first quarter 2018 financial results before market open on Thursday, April 26, 2018. InterDigital executives will host a conference call that same day at 10:00 a.m. Eastern Time to discuss the company's financial performance and other company matters.
WILMINGTON, Del., April 04, 2018 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that the company’s patent licensing subsidiaries have signed a multi-year, worldwide, non-exclusive, royalty-bearing patent license agreement with Kyocera Corporation.
S-8 POS As filed with the Securities and Exchange Commission on April 3, 2018 Registration No. 333-218755 Registration No. 333-159743 Re
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET